Status:
COMPLETED
Quantifying the Epidemiological Impact of Targeted Indoor Residual Spraying on Aedes-borne Diseases
Lead Sponsor:
Emory University
Collaborating Sponsors:
National Institute of Allergy and Infectious Diseases (NIAID)
Conditions:
Aedes-borne Diseases
Dengue
Eligibility:
All Genders
2-15 years
Phase:
NA
Brief Summary
The objective of this trial is evaluate the efficacy of Targeted Indoor Residual Spraying (TIRS) in preventing symptomatic disease caused by Aedes-borne diseases (ABDs) in children 2 to 15 years of ag...
Detailed Description
Contemporaneous urban vector control (truck-mounted ultra-low volume spraying, thermal fogging, larviciding) has failed to contain dengue epidemics and to prevent the global range expansion of Aedes-b...
Eligibility Criteria
Inclusion
- Household Level
- Household is located within the bounds of a study cluster (5x5 city-block clusters)
- City block has at least 60% premises that are residential
- Individual Level
- 2 or more and up to 15 years of age at the time of initial enrollment
- Living in a house that consented to TIRS (for children in TIRS cluster)
Exclusion
- Household Level
Key Trial Info
Start Date :
November 3 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 28 2024
Estimated Enrollment :
4461 Patients enrolled
Trial Details
Trial ID
NCT04343521
Start Date
November 3 2020
End Date
April 28 2024
Last Update
September 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Universidad Autonoma de Yucatan
Mérida, Yucatán, Mexico, 97203